Results 231 to 240 of about 244,434 (305)
Manufacturing and clinical applications of non‐CAR‐T immune effector cells
Transfusion, EarlyView.
Thane Kubik +2 more
wiley +1 more source
ABSTRACT Background and Aims Immunotherapies for cancers are tested in large numbers of clinical trials. It is difficult for clinicians and researchers to stay current with the evidence, and traditional systematic reviews and clinical guidelines are not suited to ensure a continued overview of all trials and their results.
Kim Boesen +6 more
wiley +1 more source
Expression of Human Herpes Virus 6, 7, Epstein-Barr Virus and Cytomegalovirus in Patients with Diverse Adverse Cutaneous Reactions to Drug. [PDF]
Ryoo YW, Lee JB, Kim WO, Kim SA.
europepmc +1 more source
ABSTRACT A 28‐year‐old male with paroxysmal nocturnal haemoglobinuria (PNH) presented with headache, nasal bridge discomfort and haemoglobinuria. He developed a macular‐papular rash which rapidly progressed into purpura, necrosis and peri‐orbital oedema. Investigations demonstrated severe haemolytic anaemia and acute parvovirus B19 infection.
Louise J. Potter +9 more
wiley +1 more source
ABSTRACT Human mpox, formerly known as monkeypox, has twice been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization, in 2022 and 2024. Despite this, global access to rapid, reliable diagnostics remains limited, hindering outbreak control and equitable clinical response. To address this gap, we developed
Hong Chang +8 more
wiley +1 more source
ABSTRACT Little is known about natural humoral immunity against recurrent HPV DNA detection. The objective of this study was to asses the risk of cervical HPV16 DNA detection in unvaccinated women according to HPV16 IgG and IgM seroreactivity status. We analyzed data from 618 women (mean age of 32 years) participating in the Ludwig–McGill cohort. Women
Andrea Trevisan +5 more
wiley +1 more source
ABSTRACT Herpes simplex virus Type 1 (HSV‐1) is a prevalent infectious agent globally, often causing oral infections like gingivostomatitis. The ICP0 protein of HSV‐1 exacerbates infection severity by inhibiting antiviral responses. Our study explored how combinations of CAPE (caffeic acid phenethyl ester) and acyclovir influenced immune responses in ...
Merve Sen, Sefa Celik
wiley +1 more source
Rapid detection of human herpes virus by next-generation sequencing in a patient with encephalitis. [PDF]
Zhang Y, Hong K, Zou Y, Bu H.
europepmc +1 more source

